Back
VanEck Pharmaceutical ETF Vs. Tekla Healthcare Opportunities Fund Industry Stock Comparison
Sell
48
PPH
VanEck Pharmaceutical ETF
Last Price:
96.32
Seasonality Move:
1.21%
Sell
48
THQ
Tekla Healthcare Opportunities Fund
Last Price:
21.96
Seasonality Move:
-1.03%
Sell
48
VanEck Pharmaceutical ETF (PPH)
is a Sell
Is VanEck Pharmaceutical ETF a Buy, Sell or Hold?
- The current VanEck Pharmaceutical ETF [PPH] share price is $96.39. The Score for PPH is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- PPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Tekla Healthcare Opportunities Fund (THQ)
is a Sell
Is Tekla Healthcare Opportunities Fund a Buy, Sell or Hold?
- The current Tekla Healthcare Opportunities Fund [THQ] share price is $22.06. The Score for THQ is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- THQ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PPH Stock Price Chart
What is VanEck Pharmaceutical ETF's stock price today?
-
The VanEck Pharmaceutical ETF share price today is $96.39
The current trend is moderately bearish and PPH is experiencing slight selling pressure.
THQ Stock Price Chart
What is Tekla Healthcare Opportunities Fund's stock price today?
-
The Tekla Healthcare Opportunities Fund share price today is $22.06
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and THQ is experiencing buying pressure, which is a positive indicator for future bullish movement.
PPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.37 | Buy |
| Relative Strength Index (14 RSI): | 46.23 | Sell |
| Chaikin Money Flow: | -21198 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (96.79 - 98.45) | Sell |
| Bollinger Bands (100): | (89.92 - 96.2) | Buy |
THQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.17 | Buy |
| Relative Strength Index (14 RSI): | 62.38 | Buy |
| Chaikin Money Flow: | 103686 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.46 - 21.88) | Buy |
| Bollinger Bands (100): | (20.13 - 21.55) | Buy |
PPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 97.27 | Sell |
| 20-day SMA: | 97.75 | Sell |
| 50-day SMA: | 95.44 | Buy |
| 200-day SMA: | 89.53 | Buy |
| 8-day EMA: | 97.17 | Sell |
| 20-day EMA: | 97.14 | Sell |
| 50-day EMA: | 95.7 | Buy |
| 200-day EMA: | 90.11 | Buy |
THQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.87 | Buy |
| 20-day SMA: | 21.74 | Buy |
| 50-day SMA: | 21.47 | Buy |
| 200-day SMA: | 19.93 | Buy |
| 8-day EMA: | 21.89 | Buy |
| 20-day EMA: | 21.73 | Buy |
| 50-day EMA: | 21.4 | Buy |
| 200-day EMA: | 20.19 | Buy |
VanEck Pharmaceutical ETF Earnings Growth & PPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Tekla Healthcare Opportunities Fund Earnings Growth & THQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
VanEck Pharmaceutical ETF Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Tekla Healthcare Opportunities Fund Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||